Healthy Profits, Healthy Rewards: Thyrocare’s ₹18 Dividend Headlines a Stellar Quarter

Thyrocare Technologies reported a robust close for FY2024-25 with the declaration of a final dividend of ₹21 per share following a robust financial performance during the March quarter. The group reported consolidated revenue from operations of ₹1.87 billion, indicating sustained momentum in its healthcare services and diagnostics. Net profit for the quarter was at ₹217 million, which highlights Thyrocare's robustness and operational excellence in a challenging environment.

These findings reaffirm the leadership of Thyrocare in the diagnostic industry and its focus on providing value to shareholders.

 

Sources: Moneycontrol, BlinkX, INDmoney